Chart Industries (GTLS) 8-K Regulation FD Disclosure

CHART INDUSTRIES, INC.

BARCLAYS CAPITAL

CEO ENERGY-POWER CONFERENCE

September 6, 2011

Exhibit 99.1

Disclosure

Forward-Looking

Statements:

This

presentation

includes

“forward-looking

statements”

within

the

meaning

of

the

Private

Securities

Litigation

Reform

Act

of

1995.

The

use

of

words

such

as

“may”,

“might”,

“should”,

“will”,

“expect”,

“plan”,

“anticipate”,

“believe”,

“estimate”,

“project”,

“forecast”,

“outlook”,

“intend”,

“future”,

“potential”

or

“continue”,

and

other

similar

expressions

are

intended

to

identify

forward-looking

statements.

All

of

these

forward-looking

statements

are

based

on

estimates

and

assumptions

by

our

management

as

of

the

date

of

this

presentation

that,

although

we

believe

to

be

reasonable,

are

inherently

uncertain.

Forward-looking

statements

involve

risks

and

uncertainties

that

could

cause

the

Company’s

actual

results

or

circumstances

to

differ

materially

from

those

expressed

or

implied

by

forward-looking

statements.

These

risks

and

uncertainties

include,

among

others,

the

following:

the

cyclicality

of

the

markets

that

the

Company

serves;

a

delay,

significant

reduction

in

or

loss

of

purchases

by

large

customers;

fluctuations

in

energy

prices;

changes

in

government

energy

policy

or

failure

of

expected

changes

in

policy

to

materialize; uncertainties associated with pending legislative initiatives for the use of natural gas as

a

transportation

fuel;

competition;

the

negative

impacts

of

downturns

in

economic

and

financial

conditions

on

our

business;

our

ability

to

manage

our

fixed-price

contract

exposure;

our

reliance

on

key

suppliers

and

potential

supplier

failures

or

defects;

the

modification

or

cancellation

of

orders

in

our

backlog;

changes

in

government

healthcare

regulations

and

reimbursement

policies;

general

economic,

political,

business

and

market

risks

associated

with

the

Company’s

global

operations

and

transactions;

fluctuations

in

foreign

currency

exchange

and

interest

rates;

the

Company’s

ability

to

successfully

manage

its

costs

and

growth,

including

its

ability

to

successfully

manage

operational

expansions

and

the

challenges

associated

with

efforts

to

acquire

and

integrate

new

product

lines

or

businesses;

the

financial

distress

of

third

parties;

the

loss

of

key

employees

and

deterioration

of

employee

or

labor

relations;

the

pricing

and

availability

of

raw

materials;

the

regulation

of

our

products

by

the

U.S.

Food

&

Drug

Administration

and

other

governmental

authorities;

potential

future

impairment

of

the

Company’s

significant

goodwill

and

other

intangibles;

the

cost

of

compliance

with

environmental,

health

and

safety

laws;

additional

liabilities

related

to

taxes;

the

impact

of

severe

weather;

litigation

and

disputes

involving

the

Company,

including

product

liability,

contract,

warranty,

employment

claims

and

environmental;

and

volatility

and

fluctuations

in

the

price

of

the

Company’s

stock.

For

a

discussion

of

these

and

additional

risks

that

could

cause

actual

results

to

differ

from

those

described

in

the

forward-looking

statements,

see

disclosure

under

Item

1A.

“Risk

Factors”

in

the

Company’s

most

recent

Annual

Report

on

Form

10-K

and

other

recent

filings

with

the

Securities

and

Exchange

Commission,

which

should

be

reviewed

carefully.

Please

consider

the

Company’s

forward-looking

statements

in

light

of

these

risks. Any forward-looking statement speaks only as of its date. We undertake no obligation to

publicly

update

or

revise

any

forward-looking

statement,

whether

as

a

result

of

new

information,

future

events

or

otherwise,

except

as

required

by

law.

1

GTLS: GAS TO LIQUID SYSTEMS

Technology leader that provides high-end equipment to the energy industry, which is the

largest end-user of Chart’s products

One of the leading suppliers in all primary markets served

Global footprint for our operations on four continents with approximately 3,345 employees

Worldwide earnings with approximately 60% of sales derived from outside the U.S.

Company Overview

Chart Industries is a leading provider of highly engineered cryogenic equipment

for the hydrocarbon, industrial gas, and biomedical markets

Asia

21%

U.S.

44%

Americas

(Non-US)

10%

RoW

2%

Europe

23%

LTM

June

2011Sales

by

Segment

Energy

47%

BioMedical

27%

General

Industrial

26%

LTM

June

2011

Sales

by

Region

LTM

June

2011

Sales

by

End-User

Energy &

Chemicals

26%

Distribution

& Storage

48%

BioMedical

26%

2

GTLS: GAS TO LIQUID SYSTEMS

Energy & Chemicals (E&C) Segment Overview

Heat Exchanger

Cold Box

Production

Heat

Exchangers

80%

Cold Boxes and

LNG VIP

20%

LTM June 2011 Sales by Product / Region

Highlights

Technology

leader

-

providing

heat

exchangers

and

cold

boxes

critical

to

LNG,

Olefin

petrochemicals,

natural

gas

processing

and

industrial

gas

markets

–

Separation,

liquefaction

and

purification

of

hydrocarbon

and

industrial

gases

Market

leader

–

leading

market

positions

worldwide

Manufacturing

leader

-

one

of

three

global

suppliers

of

mission-critical

LNG

and

LNG

liquefaction

equipment

Selected Products

Americas

(Non-US)

15%

RoW 4%

Asia

30%

U.S.

49%

Europe

2%

3

GTLS: GAS TO LIQUID SYSTEMS

Distribution & Storage (D&S) Segment Overview

LTM June 2011 Sales by Product / Region

Highlights

Balanced

customer

base

-

45%

of

segment

sales

derived

from

products

used

in

energy

applications

Strategic

footprint

–

manufacturing

located

near

growing

end

markets

and

lower-cost

countries

–

Positioned

to

capitalize

on

strong

expected

growth

in

Asia

and

Eastern

Europe

(supplemented

by

3

rd

Qtr.

acquisition

in

Germany)

–

Continued

investment

in

key

global

manufacturing

facilities

Bulk

MicroBulk

Distribution

Storage

Selected Products

Satellite

LNG Storage

Bulk Storage

Systems

34%

Packaged Gas

Systems

31%

VIP, Systems

and Components

11%

Parts, Repair and On-

Site Service

11%

Beverage Liquid

CO2 Systems

7%

LNG Terminals

and Vehicle Fuel

Systems 6%

Americas

(Non-US)

10%

RoW

2%

Asia

21%

U.S.

45%

Europe

22%

4

GTLS: GAS TO LIQUID SYSTEMS

BioMedical Segment Overview

LTM June 2011 Sales by Product / Region

Highlights

Strong

growth

-

increase

in

oxygen

respiratory

therapy

and

biomedical

research,

led

by

international

markets,

expected

Robust

end

markets

include:

–

Home

healthcare

and

nursing

homes

–

Hospitals

and

long-term

care

–

Biomedical

and

pharmaceutical

research

–

Animal

breeding

Portable Oxygen

Lab Storage

Stainless Steel Freezer

End-Use Consumption

Respiratory

Therapy

Systems

67%

Biological

Storage

Systems

33%

Selected Products

Americas

(Non-US)

5%

U.S.  

39%

Europe

45%

Asia

10%

RoW

1%

5

GTLS: GAS TO LIQUID SYSTEMS

Global Manufacturing and Distribution Platform

Operating

leverage

provides

the

flexibility

to

expand

and

reduce

capacity

as

needed

with

minimal

capital

expenditures

Major

manufacturing

locations

include:

China,

Changzhou

(D&S

and

E&C)

and

Chengdu

(BioMedical)

Czech

Republic,

Decin

(D&S)

Georgia,

Canton

and

Minnesota,

New

Prague

(D&S

and

BioMedical)

Wisconsin,

La

Crosse,

Louisiana,

New

Iberia

and

Oklahoma,

Tulsa

(E&C)

Expansion

of

facilities

in

China,

Changzhou

and

Louisiana

are

currently

in

process

Manufacturing

facilities

are

strategically

located

in

lower-cost

countries

and

near

centers

of

demand

Corporate

Energy & Chemicals

Distribution & Storage

BioMedical

Asia-Pacific

North America

Europe

6

GTLS: GAS TO LIQUID SYSTEMS

BioMedical

•Aging demographics

•

Product expansion

•

Increasing biological

research

Growth Opportunities

7

D&S

•Global LNG opportunity

•

Strong relationships with

Industrial Gas customers

•

Demand for Industrial Gas

projected to increase 8%

per year

E&C

•Global base load LNG

projects

•

Growth in natural gas

processing

•

Emerging market

opportunities

GTLS: GAS TO LIQUID SYSTEMS

Natural

gas

expansion

-

Natural

gas

demand

is

expected

to

continue

to

grow

at

a

pace

faster

than

coal

and

oil,

and

will

be

heavily

weighted

towards

emerging

economies,

which

is

expected

to

drive

demand

for Chart’s products

LNG

growth

leader

–

The

natural

gas

industry

is

expected

to

invest

approximately

$720

billion

in

LNG

facilities

from

2009

to

2035,

with

LNG

reaching

25%

of

world

demand

in

2035

(Source:

International

Energy

Agency

–

World

Energy

Outlook

2011,

Golden

Age

of

Gas

Scenario)

Natural Gas Expected To Grow Globally

Source: ExxonMobil –

Outlook for Energy, A View to 2030

8

GTLS: GAS TO LIQUID SYSTEMS

Increasing

natural

gas

penetration

as

a

viable

energy

source

and

transportation

fuel

due

to

its

high

energy

density,

lower

costs,

cleaner

emissions

profile,

and

plentiful

supply

due

to

improved

drilling

technologies

(e.g.

shale

gas).

U.S.

trucking

fleets

beginning

to

convert

to

natural

gas

as

a

fuel.

China’s

twelfth

5-year

plan

(2011

-

2015)

mandates

an

increase

of

gas

as

a

percentage

of

energy

consumption

from

less

than

4%

to

over

8% 

Dramatic

increase

in

imported

LNG

in

China

has

already

begun

and

is

expected

to

accelerate,

with

aggressive

investment

in

infrastructure,

including

LNG

transportation

and

storage

equipment

Lack

of

pipeline

infrastructure

in

China

requires

“virtual

pipeline”

with

LNG

Chart

provides

a

broad

offering

of

products

and

solutions

for

the

full

LNG

value

chain:

LNG

liquefiers,

transportation

equipment,

terminal

storage

equipment

and

vehicle

tanks

for

both

on-road

and

off-road

heavy

duty

vehicles

and

marine

applications

LNG Value Chain Opportunities

9

GTLS: GAS TO LIQUID SYSTEMS

Core Competencies

Proprietary Technology

Global Platform

Financial Strength

New Products

New Segments

New Geographies

Current Platforms

E&C

D&S

BioMedical

New Platform

+

=

Business Differentiators

Growth Enablers

Value Added Acquisitions

Acquisitions

Enhancing

Shareholder

Value

Continue

investment

in

current

platforms

-10

acquisitions

since

2005

Actively

seeking

new

business

platform

10

GTLS: GAS TO LIQUID SYSTEMS

Strong Track Record of Successful Execution

¹Included in 2005 are non-recurring costs of $26.5 million for the acquisition of Chart  Industries by

First Reserve

During

last

growth

cycle

Company

leveraged

its

flexible

manufacturing

platform

resulting

in

operating

income

growth

that

outpaced

sales

Flexible

cost

structure

and

good

execution

allowed

for

aggressive

response

to

economic

downturn

resulting

in

higher

operating

income

level

than

last

cycle

low

point

11

Similar

or

higher

growth,

leveraged

by

acquisitions,

expected

to

occur

again

during

the

current

growth

cycle 

First

half

2011

sales

of

$363.6

million

continue

to

ramp

up

significantly

GTLS: GAS TO LIQUID SYSTEMS

Historical

Orders

and

Backlog

Backlog

12

Orders

GTLS: GAS TO LIQUID SYSTEMS

Very Stable Business Model

•Attractive industry with long-term

customer relationships

•

Solid platform with worldwide

presence and leading market

positions in all segments

Summary of Investment Highlights

13

Strong Balance Sheet

•

Strong organic earnings should provide

substantial free cash flow and liquidity

•

Permit continued accretive organic /

inorganic growth

Positioned for Significant Growth

•Exploit LNG and NG growth

•

Opportunities with global

infrastructure build-out

•

New product development and

innovation

•Expanded new business and

inorganic pipeline

Chart continues to represent a unique investment opportunity to capitalize on global

energy demand, growth in natural gas use, and biomedical opportunities

Flexible / Low Cost Capital Structure

•

7 year, $250 million convertible, hedged

financing with 2% cash interest cost

•

Actively monitor financing opportunities

with a view toward cost efficiency and 

financial flexibility